Shelly Singh-Gryzbon

Title: Innovations by Shelly Singh-Gryzbon in Thrombosis Prediction

Introduction

Shelly Singh-Gryzbon is an accomplished inventor based in Atlanta, GA. She has made significant contributions to the field of medical technology, particularly in the area of heart valve replacements. Her innovative work focuses on predicting thrombosis, which is crucial for improving patient outcomes in transcatheter aortic valve replacement (TAVR) procedures.

Latest Patents

Shelly Singh-Gryzbon holds a patent for "Systems and methods for predicting thrombosis for heart valve replacements." This patent outlines methods for determining the likelihood of thrombosis based on patient-specific anatomic, valve, and flow parameters. The methods disclosed in her patent are designed to select a transcatheter aortic valve that minimizes the risk of thrombosis after TAVR procedures. The patent details the correlation of various fluid flow and geometric parameters, including stasis volume, neo-sinus volume, kinematic viscosity, and wall shear stress, among others. These parameters are utilized to derive mathematical models that predict the likelihood of thrombosis effectively.

Career Highlights

Throughout her career, Shelly has worked with notable organizations such as the Ohio State Innovation Foundation and Georgia Tech Research Corporation. Her experience in these institutions has allowed her to develop and refine her innovative ideas in medical technology.

Collaborations

Shelly has collaborated with talented individuals in her field, including Lakshmi Prasad Dasi and Amirsepehr Azimian. These collaborations have contributed to the advancement of her research and the successful development of her patented technologies.

Conclusion

Shelly Singh-Gryzbon's work in predicting thrombosis for heart valve replacements represents a significant advancement in medical technology. Her innovative methods have the potential to enhance patient care and improve outcomes in heart valve replacement procedures.